InflaRx (IFRX) Total Liabilities (2016 - 2026)

InflaRx's Total Liabilities history spans 10 years, with the latest figure at $14.0 million for Q1 2026.

  • On a quarterly basis, Total Liabilities fell 19.23% to $14.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $14.0 million, a 19.23% decrease, with the full-year FY2025 number at $15.9 million, up 1.9% from a year prior.
  • Total Liabilities hit $14.0 million in Q1 2026 for InflaRx, down from $15.9 million in the prior quarter.
  • Over the last five years, Total Liabilities for IFRX hit a ceiling of $23.1 million in Q3 2025 and a floor of $8.3 million in Q1 2023.
  • Historically, Total Liabilities has averaged $15.1 million across 5 years, with a median of $14.3 million in 2022.
  • Biggest five-year swings in Total Liabilities: tumbled 62.95% in 2023 and later surged 61.49% in 2024.
  • Tracing IFRX's Total Liabilities over 5 years: stood at $14.3 million in 2022, then skyrocketed by 32.3% to $19.0 million in 2023, then fell by 17.72% to $15.6 million in 2024, then grew by 1.9% to $15.9 million in 2025, then dropped by 11.65% to $14.0 million in 2026.
  • Business Quant data shows Total Liabilities for IFRX at $14.0 million in Q1 2026, $15.9 million in Q4 2025, and $23.1 million in Q3 2025.